These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 20367270)
1. Usefulness of power Doppler ultrasonography and superparamagnetic iron oxide enhanced magnetic resonance imaging for diagnosis of focal nodular hyperplasia of the liver after treatment of neuroblastoma. Sugito K; Kusafuka T; Kawashima H; Uekusa S; Furuya T; Ohashi K; Inoue M; Ikeda T; Koshinaga T; Maebayashi T Pediatr Hematol Oncol; 2010 Apr; 27(3):250-6. PubMed ID: 20367270 [TBL] [Abstract][Full Text] [Related]
2. Focal nodular hyperplasia of the liver: usefulness of superparamagnetic iron oxide-enhanced magnetic resonance imaging. Okada T; Sasaki F; Kamiyama T; Nakagawa T; Nakanishi K; Kobayashi R; Itoh T; Ota S; Todo S J Pediatr Surg; 2005 Mar; 40(3):E21-5. PubMed ID: 15793708 [TBL] [Abstract][Full Text] [Related]
3. MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): an intra-individual comparison. Grazioli L; Morana G; Kirchin MA; Caccia P; Romanini L; Bondioni MP; Procacci C; Chiesa A J Magn Reson Imaging; 2003 May; 17(5):593-602. PubMed ID: 12720270 [TBL] [Abstract][Full Text] [Related]
4. [Focal nodular hyperplasia of the liver: imaging findings with emphasis on the findings of superparamagnetic iron oxide-enhanced MR imaging]. Han JK; Kim SH Korean J Hepatol; 2006 Mar; 12(1):116-9. PubMed ID: 16565614 [No Abstract] [Full Text] [Related]
5. MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): an intra-individual comparison. Fröhlich JM J Magn Reson Imaging; 2004 Mar; 19(3):375-6; author reply 376. PubMed ID: 14994308 [No Abstract] [Full Text] [Related]
6. Focal nodular hyperplasia: lesion characteristics on state-of-the-art MRI including dynamic gadolinium-enhanced and superparamagnetic iron-oxide-uptake sequences in a prospective study. Terkivatan T; van den Bos IC; Hussain SM; Wielopolski PA; de Man RA; IJzermans JN J Magn Reson Imaging; 2006 Oct; 24(4):864-72. PubMed ID: 16947339 [TBL] [Abstract][Full Text] [Related]
7. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis]. Stroszczynski C; Gaffke G; Gretschel S; Rambow A; Jost D; Schlecht I; Schneider U; Schicke B; Hohenberger P; Gebauer B; Felix R Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106 [TBL] [Abstract][Full Text] [Related]
8. Atypical focal nodular hyperplasia of the liver: imaging features of nonspecific and liver-specific MR contrast agents. Ba-Ssalamah A; Schima W; Schmook MT; Linnau KF; Schibany N; Helbich T; Reimer P; Laengle F; Wrba F; Kurtaran A; Ryan M; Mann FA AJR Am J Roentgenol; 2002 Dec; 179(6):1447-56. PubMed ID: 12438034 [TBL] [Abstract][Full Text] [Related]
9. [The characterization value of feridex-enhanced MR imaging for focal hepatic lesions in reference to their histological pathology]. Yang HF; Zhou XP; Yu JQ; Song B; Guang YS; Zhang HY; Chen X Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):548-50. PubMed ID: 16042902 [No Abstract] [Full Text] [Related]
10. Perfusion study of liver lesions with superparamagnetic iron oxide: distinguishing hepatocellular carcinoma from focal nodular hyperplasia. Saito K; Sugimoto K; Nishio R; Araki Y; Moriyasu F; Kakizaki D; Tokuuye K Clin Imaging; 2009; 33(6):447-53. PubMed ID: 19857805 [TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma in association with hepatic focal nodular hyperplasia. Langrehr JM; Pfitzmann R; Hermann M; Radke C; Neuhaus P; Pech M; Denecke T; Felix R; Hänninen EL Acta Radiol; 2006 May; 47(4):340-4. PubMed ID: 16739692 [TBL] [Abstract][Full Text] [Related]
12. Thioguanin-induced nodular regenerative hyperplasia of the liver-ROC analysis of different MR techniques. Zech CJ; Seiderer J; Reinisch W; Ochsenkuhn T; Schima W; Diebold J; Wrba F; Reiser MF; Schoenberg SO Eur Radiol; 2007 Jul; 17(7):1898-905. PubMed ID: 17221208 [TBL] [Abstract][Full Text] [Related]
13. Focal nodular hyperplasia of the liver: serial MRI with Gd-DOTA, superparamagnetic iron oxide, and Gd-EOB-DTPA. Kacl GM; Hagspiel KD; Marincek B Abdom Imaging; 1997; 22(3):264-7. PubMed ID: 9107647 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of enhancement patterns of focal nodular hyperplasia in contrast-enhanced, wide-band phase-inversion harmonic power Doppler imaging of the liver. Janica J; Serwatka W; Polaków J; Ustymowicz A; Walecki J; Ladny JR; Dobrzycki S Med Sci Monit; 2004 Jun; 10 Suppl 3():17-21. PubMed ID: 16538193 [TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and treatment of hepatic focal nodular hyperplasia: report of 114 cases]. Li AJ; Zhou WP; Wu MC Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(5):321-3. PubMed ID: 16635391 [TBL] [Abstract][Full Text] [Related]
16. Focal nodular hyperplasia in children following treatment of hemato-oncologic diseases. Freidl T; Lackner H; Huber J; Sovinz P; Moser A; Schroettner B; Schwinger W; Urban C Klin Padiatr; 2008; 220(6):384-7. PubMed ID: 18949676 [TBL] [Abstract][Full Text] [Related]
17. Focal nodular hyperplasia: intraindividual comparison of dynamic gadobenate dimeglumine- and ferucarbotran-enhanced magnetic resonance imaging. Marin D; Iannaccone R; Laghi A; Catalano C; Murakami T; Hori M; Kim T; Passariello R J Magn Reson Imaging; 2007 Apr; 25(4):775-82. PubMed ID: 17348002 [TBL] [Abstract][Full Text] [Related]
18. Detection and characterization of focal hepatic lesions: mangafodipir vs. superparamagnetic iron oxide-enhanced magnetic resonance imaging. Kim MJ; Kim JH; Lim JS; Oh YT; Chung JJ; Choi JS; Lee WJ; Kim KW J Magn Reson Imaging; 2004 Oct; 20(4):612-21. PubMed ID: 15390224 [TBL] [Abstract][Full Text] [Related]
19. [Focal liver lesions. A comparison between magnetic resonance under base conditions and after a superparamagentic contrast medium]. Finazzo M; Midiri M; Gallo C; Bartolotta TV; Luca A Radiol Med; 1998 Jun; 95(6):599-607. PubMed ID: 9717542 [TBL] [Abstract][Full Text] [Related]
20. [Focal nodular hyperplasia of the liver in a young female]. Lakomy EA; Pajuro R; Dubaniewicz M; Jaśkiewicz K Pol Merkur Lekarski; 2001 Dec; 11(66):503-6. PubMed ID: 11899848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]